Brief: Hansoh Pharmaceutical Announces Strategic Collaboration And License Agreement With Roche
Mon 11:15
BRIEF-Hansoh Pharmaceutical Announces Strategic Collaboration And License Agreement With Roche Oct 19 (Reuters) - Hansoh Pharmaceutical Group Company Limited 3692.HK:
STRATEGIC COLLABORATION AND LICENSE AGREEMENT WITH ROCHE
TO RECEIVE UPFRONT PAYMENT OF $400 MILLION AND FIRST ANNIVERSARY PAYMENT OF $110 MILLION
ELIGIBLE TO RECEIVE OVER $15 BILLION IN MILESTONE PAYMENTS AND TIERED ROYALTIES
RETAINS ALL RIGHTS TO PROGRAMS IN CHINESE MAINLAND, HONG KONG, MACAU AND TAIWAN
MAY SELECT UP TO TWO PROGRAMS FOR DEVELOPMENT OUTSIDE CHINESE MAINLAND, HONG KONG, MACAU AND TAIWAN
ON OCT 17, UNITS ENTERED STRATEGIC COLLABORATION AND LICENSE AGREEMENT WITH F. HOFFMANN-LA ROCHE
Further company coverage: 3692.HK
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Hansoh Pharmaceutical
See all newsHansoh Pharmaceutical jumps most in 8 weeks on Roche tie-up
Deals of the day-Mergers and acquisitions
Factbox: Major drugmakers turn to China for licensing deals
China's Hansoh Pharma strikes drug deal with Roche worth over $15 billion (updated)
China's Hansoh Pharma strikes drug deal with Roche worth over $15 billion